alpha-aminopyridine has been researched along with Leukemia, Pre-B-Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, H; Yang, X; Yu, Q; Zhou, J | 1 |
| Accordi, B; Basso, G; Bresolin, S; Cortese, G; Mariotto, E; Porcù, E; Serafin, V; Veltri, G | 1 |
| Baloglu, E; Chen, Y; Chien, W; Ding, LW; Gery, S; Jiang, YY; Koeffler, HP; Lill, M; Lin, DC; Madan, V; Mayakonda, A; Müschen, M; Park, E; Senapedis, W; Sudo, M; Sun, QY; Takao, S; Xu, L | 1 |
| Accordi, B; Basso, G; Bortolozzi, R; Mattiuzzo, E; Trentin, L; Viola, G | 1 |
| Costa, FF; Favaro, P; Lopes, MR; Machado-Neto, JA; Morini, BC; Pereira, JK; Saad, ST; Traina, F | 1 |
| Eckert, C; Einsiedel, HG; Fichtner, I; Henze, G; Kawan, L; Seeger, K; Witt, O | 1 |
6 other study(ies) available for alpha-aminopyridine and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Upregulation of CD22 by Chidamide promotes CAR T cells functionality.
Topics: Aminopyridines; B-Lymphocytes; Benzamides; Cell Line, Tumor; Gene Expression; Histone Deacetylase Inhibitors; Histones; Humans; Immunotherapy, Adoptive; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Receptors, Chimeric Antigen; Sialic Acid Binding Ig-like Lectin 2; T-Lymphocytes; Up-Regulation | 2021 |
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
Topics: Aminopyridines; Cell Proliferation; Child; Core Binding Factor Alpha 2 Subunit; Cyclohexylamines; Drug Resistance, Neoplasm; Humans; Indazoles; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrazines; Pyridines; Pyrimidines; Syk Kinase; Tumor Cells, Cultured | 2019 |
Targeting the vulnerability to NAD
Topics: Acrylamides; Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Female; Humans; Male; Mice; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All).
Topics: Aminopyridines; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Purines | 2018 |
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Survival; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Humans; Jurkat Cells; Molecular Targeted Therapy; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Signal Transduction | 2015 |
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Heterologous | 2006 |